Related Experiment Videos
Abstract:
Twenty-one episodes of status epilepticus (SE) were each treated with 1 to 9 mg (mean, 4 mg) of intravenous lorazepam. All patients with generalized tonic-clonic ( GTC ) SE responded within 15 minutes. Nine (82%) of the 11 patients with episodes of partial SE with altered responsiveness responded poorly. Respiratory depression occurred in five instances (two requiring intubation) and was associated with transient loss of brain-stem reflexes, hypotension, and decorticate posturing in three cases. Generalized tonic-clonic SE was transformed into partial SE with altered responsiveness in three patients. In an additional four patients, marked lethargy developed. Lorazepam appears effective in controlling GTC SE but only occasionally effective in partial SE with altered responsiveness.
Insights
Intravenous lorazepam effectively controls generalized tonic-clonic (GTC) status epilepticus (SE). However, it shows limited efficacy for partial SE with altered responsiveness and can cause respiratory depression.
Area of Science:
- Neurology
- Pharmacology
- Critical Care Medicine
Background:
- Status epilepticus (SE) is a neurological emergency requiring prompt treatment.
- Intravenous lorazepam is a common first-line agent for SE management.
- Different seizure types may exhibit variable responses to pharmacotherapy.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous lorazepam in treating different types of status epilepticus.
- To compare treatment outcomes between generalized tonic-clonic SE and partial SE with altered responsiveness.
Main Methods:
- Retrospective analysis of 21 episodes of status epilepticus treated with intravenous lorazepam (1-9 mg).
- Categorization of SE into generalized tonic-clonic (GTC) and partial with altered responsiveness.
- Assessment of patient response, adverse events, and seizure transformation.
Main Results:
- All patients with GTC SE (100%) responded to lorazepam within 15 minutes.
- Only 18% (2/11) of patients with partial SE with altered responsiveness showed a good response.
- Adverse events included respiratory depression (n=5), requiring intubation in two cases, and marked lethargy (n=4).
- Seizure transformation from GTC SE to partial SE with altered responsiveness occurred in three patients.
Conclusions:
- Intravenous lorazepam is highly effective for controlling generalized tonic-clonic status epilepticus.
- Lorazepam demonstrates limited efficacy in managing partial status epilepticus with altered responsiveness.
- Close monitoring for adverse events, particularly respiratory depression, is crucial during lorazepam treatment for SE.